康臣药业12月16日斥资117.98万港元回购8万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Company Actions - The company plans to repurchase 80,000 shares at a total cost of HKD 1.1798 million [1] - The buyback price per share ranges from HKD 14.74 to HKD 14.75 [1]